- Home
- MLYS vs PAGP Comparison
MLYS vs PAGP Comparison
Compare MLYS & PAGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- PAGP
- Stock Information
- Founded
- MLYS 2019
- PAGP 2013
- Country
- MLYS United States
- PAGP United States
- Employees
- MLYS N/A
- PAGP N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- PAGP Natural Gas Distribution
- Sector
- MLYS Health Care
- PAGP Energy
- Exchange
- MLYS Nasdaq
- PAGP Nasdaq
- Market Cap
- MLYS 2.9B
- PAGP 3.5B
- IPO Year
- MLYS 2023
- PAGP 2013
- Fundamental
- Price
- MLYS $40.40
- PAGP $17.90
- Analyst Decision
- MLYS Strong Buy
- PAGP Hold
- Analyst Count
- MLYS 6
- PAGP 8
- Target Price
- MLYS $46.40
- PAGP $19.86
- AVG Volume (30 Days)
- MLYS 1.5M
- PAGP 1.5M
- Earning Date
- MLYS 11-10-2025
- PAGP 11-05-2025
- Dividend Yield
- MLYS N/A
- PAGP 8.51%
- EPS Growth
- MLYS N/A
- PAGP 11.06
- EPS
- MLYS N/A
- PAGP 0.95
- Revenue
- MLYS N/A
- PAGP $46,917,000,000.00
- Revenue This Year
- MLYS N/A
- PAGP N/A
- Revenue Next Year
- MLYS N/A
- PAGP $11.23
- P/E Ratio
- MLYS N/A
- PAGP $56.96
- Revenue Growth
- MLYS N/A
- PAGP N/A
- 52 Week Low
- MLYS $8.24
- PAGP $16.61
- 52 Week High
- MLYS $47.65
- PAGP $22.31
- Technical
- Relative Strength Index (RSI)
- MLYS 49.69
- PAGP 56.48
- Support Level
- MLYS $36.56
- PAGP $16.89
- Resistance Level
- MLYS $47.65
- PAGP $17.72
- Average True Range (ATR)
- MLYS 3.45
- PAGP 0.32
- MACD
- MLYS -0.00
- PAGP 0.08
- Stochastic Oscillator
- MLYS 50.18
- PAGP 94.86
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About PAGP Plains GP Holdings L.P. Units representing Limited Partner Interests
Plains GP Holdings LP provides transportation, storage, processing, fractionation, and marketing services for crude oil, refined products, natural gas liquids, liquefied petroleum gas, and related products. The group manages its operations through two operating segments: Crude Oil and NGL.